J&J avoiding GLP-1 space to focus on cancer drugs (JNJ:NYSE)

Pharmalittle: We're reading about an FDA review of Moderna's flu shot, J&J's focus on cancer, and more

And so, another working week will soon draw to a close — at least on this side of the pond where we have a holiday tomorrow. This means we are staring down a longer-than-usual agenda to fill. So far, we plan to manicure the Pharmalot campus and promenade extensively with the official mascots, and we hope to hold still another listening party, where the rotation will likely include this, this, this, this and this. And what about you? The great ou…

J&J avoiding GLP-1 space to focus on cancer drugs (JNJ:NYSE)

Johnson & Johnson (JNJ) stock is in focus as CEO says the company won’t pursue GLP-1 obesity drugs and instead prioritize oncology and other diseases. Read more here.